Concert Pharmaceuticals Inc.
CNCE
|
|
| |
|
| Trading Volume | 10,733,298 |
|
|
0.00 - 0.00 |
| Market Cap Full | $ 401.2M |
Quarterly +
| 2025 | 2024 | 2023 | 2022 | |
|---|---|---|---|---|
| Q1 | - | - | 43.3% | 16.2% |
| Q2 | - | - | - | 15% |
| Q3 | - | - | - | 59.1% |
| Q4 | - | - | - | -12.8% |
Monthly +
| J | F | M | A | M | J | J | A | S | O | N | D |
| 2025 | |||||||||||
|---|---|---|---|---|---|---|---|---|---|---|---|
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2024 | |||||||||||
| - | - | - | - | - | - | - | - | - | - | - | - |
| 2023 | |||||||||||
| 42.8 | 0.5 | -0.1 | - | - | - | - | - | - | - | - | - |
| 2022 | |||||||||||
| -3.8 | -0.7 | 21.6 | -14.5 | 103.2 | -33.8 | 24 | 25.2 | 2.5 | -11.2 | -19 | 21.2 |
| 2021 | |||||||||||
| -17.2 | -34.9 | -27.9 | -16.1 | -2.7 | 5 | -19.2 | 11.1 | -13.7 | -13.7 | 19.8 | -6.8 |
| 2020 | |||||||||||
| 15.2 | -11.5 | -6.5 | 12.9 | 6.4 | -6.3 | -6.8 | 3.8 | 1.9 | 5.3 | 10.5 | 10.9 |
EPS
| 2021 | 2020 | |
|---|---|---|
| Q1 | -0.7 | -0.7 |
| Q2 | 0.2 | -0.4 |
| Q3 | -0.8 | -0.6 |
| Q4 | 0 | -0.7 |
| A | -2.3 | -2.4 |